↓ Skip to main content

Cardiac safety profile of patients receiving high cumulative doses of pegylated-liposomal doxorubicin: use of left ventricular ejection fraction is of unproven value

Overview of attention for article published in Cancer Chemotherapy and Pharmacology, August 2017
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

f1000
1 research highlight platform

Citations

dimensions_citation
28 Dimensions

Readers on

mendeley
47 Mendeley
Title
Cardiac safety profile of patients receiving high cumulative doses of pegylated-liposomal doxorubicin: use of left ventricular ejection fraction is of unproven value
Published in
Cancer Chemotherapy and Pharmacology, August 2017
DOI 10.1007/s00280-017-3420-8
Pubmed ID
Authors

Keith M. Skubitz, Anne H. Blaes, Suma H. Konety, Gary S. Francis

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 47 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 47 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 8 17%
Student > Master 5 11%
Student > Doctoral Student 4 9%
Researcher 4 9%
Student > Ph. D. Student 3 6%
Other 5 11%
Unknown 18 38%
Readers by discipline Count As %
Medicine and Dentistry 8 17%
Pharmacology, Toxicology and Pharmaceutical Science 7 15%
Biochemistry, Genetics and Molecular Biology 4 9%
Arts and Humanities 1 2%
Nursing and Health Professions 1 2%
Other 6 13%
Unknown 20 43%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 September 2018.
All research outputs
#16,049,105
of 23,815,455 outputs
Outputs from Cancer Chemotherapy and Pharmacology
#1,859
of 2,501 outputs
Outputs of similar age
#200,204
of 317,021 outputs
Outputs of similar age from Cancer Chemotherapy and Pharmacology
#14
of 25 outputs
Altmetric has tracked 23,815,455 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,501 research outputs from this source. They receive a mean Attention Score of 4.1. This one is in the 20th percentile – i.e., 20% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 317,021 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 27th percentile – i.e., 27% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 25 others from the same source and published within six weeks on either side of this one. This one is in the 40th percentile – i.e., 40% of its contemporaries scored the same or lower than it.